Aktis Oncology Inc (AKTS)

Jul 27, 2026

AKTS|Akoustis Technologies Ord Shs|Price:24.170|Chg%:+0.280 - TradingKey

Jul 27, 2026

Jul 24, 2026

Has Aktis Oncology (AKTS) Fallen Far Enough To Be Below Fair Value? - simplywall.st

Jul 24, 2026

Jul 22, 2026

AKTIS ONCOLOGY INC : LEERINK PARTNERS ASSUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $33 - Bitget

Jul 22, 2026

Jul 22, 2026

Aktis Oncology Inc : Leerink Partners Assumes - Moomoo

Jul 22, 2026

Jul 22, 2026

Aktis Oncology director Ken Herrmann sells $119,274 in stock By Investing.com - Investing.com Australia

Jul 22, 2026

Jul 21, 2026

Form 4 Aktis Oncology Inc For: 21 July By Investing.com - Investing.com Nigeria

Jul 21, 2026

Jul 21, 2026

Aktis Oncology (AKTS) director sells 4,856 shares after exercising options - Stock Titan

Jul 21, 2026

Jul 21, 2026

Aktis Oncology director Ken Herrmann sells $119,274 in stock - Investing.com

Jul 21, 2026

Jul 21, 2026

Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78 - Bitget

Jul 21, 2026

Jul 20, 2026

Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54 - Bitget

Jul 20, 2026

Jul 20, 2026

AKTS Pulls Back After Recent Gains: Key Levels to Watch for Aktis Oncology (AKTS)Volatility Skew - dars.gov.et

Jul 20, 2026

Jul 20, 2026

Aktis Oncology, Inc. (AKTS) director sells 3,065 post-exercise - Stock Titan

Jul 20, 2026

Jul 20, 2026

Akoustis Technologies (AKTS) insider plans 4,856-share stock sale after option exercise - Stock Titan

Jul 20, 2026

Jul 20, 2026

AKTS Options Chain — NASDAQ:AKTS - TradingView

Jul 20, 2026

Jul 19, 2026

Enterprise value to EBIT forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 19, 2026

Jul 19, 2026

Enterprise value to revenue forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 19, 2026

Jul 18, 2026

Form 144 AKTIS ONCOLOGY For: 17 July By Investing.com - Investing.com Nigeria

Jul 18, 2026

Jul 17, 2026

Aktis Oncology, Inc. SEC Filing (Jul 17, 2026) - Stock Titan

Jul 17, 2026

Jul 17, 2026

AKTS Options Volatility — NASDAQ:AKTS - TradingView

Jul 17, 2026

Jul 17, 2026

Price to sales forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 17, 2026

Jul 15, 2026

New Options Listings Include Aktis Oncology Inc (AKTS) - GuruFocus

Jul 15, 2026

Jul 15, 2026

AKTS Maintained by JP Morgan -- Price Target Raised to $33.00 - GuruFocus

Jul 15, 2026

Jul 14, 2026

J.P. Morgan Maintains Aktis Oncology(AKTS.US) With Buy Rating, Raises Target Price to $33 - Moomoo

Jul 14, 2026

Jul 14, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 14, 2026

Jul 13, 2026

Price to book forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 13, 2026

Jul 13, 2026

Price to earnings forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 13, 2026

Jul 13, 2026

Enterprise value to EBITDA forward of Aktis Oncology, Inc. – NASDAQ:AKTS - TradingView

Jul 13, 2026

Jul 11, 2026

Aktis oncology CMO sells $1.39m in shares By Investing.com - Investing.com India

Jul 11, 2026

Jul 10, 2026

Aktis Oncology COO Ron-Bigger sells $1.39m in shares - Investing.com UK

Jul 10, 2026

Jul 10, 2026

Aktis Oncology Insider Sold Shares Worth $1,387,558, According to a Recent SEC Filing - Moomoo

Jul 10, 2026

Jul 10, 2026

Aktis Oncology COO Ron-Bigger sells $1.39m in shares By Investing.com - Investing.com Australia

Jul 10, 2026

Jul 10, 2026

Aktis oncology CMO sells $1.39m in shares - Investing.com

Jul 10, 2026

Jul 10, 2026

Form 4 Aktis Oncology Inc For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026

Jul 10, 2026

Aktis Oncology Insider Sold Shares Worth $1,388,701, According to a Recent SEC Filing - Moomoo

Jul 10, 2026

Jul 10, 2026

Aktis Oncology Insiders Sold Shares Worth Over $2.8M - TradingView

Jul 10, 2026

Jul 10, 2026

Aktis Oncology (AKTS) COO exercises 50,000 options and sells matching shares - Stock Titan

Jul 10, 2026

Jul 10, 2026

Aktis Oncology (AKTS) CMO exercises 50,000 options, sells 50,000 shares in July 8 trades - Stock Titan

Jul 10, 2026

Jul 10, 2026

AKTS Q1 2026 Earnings: Wider-Than-Expected Loss Amid Pre-Revenue Pipeline Progress - dars.gov.et

Jul 10, 2026

Jul 08, 2026

Form 144 AKTIS ONCOLOGY For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

[144] Aktis Oncology, Inc. SEC Filing - Stock Titan

Jul 08, 2026

Jul 08, 2026

Aktis Oncology (AKTS) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Jul 08, 2026

Jul 07, 2026

Certain Options of Aktis Oncology, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2026. - marketscreener.com

Jul 07, 2026

Jul 07, 2026

34,872,279 Common Stock of Aktis Oncology, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2026. - marketscreener.com

Jul 07, 2026

Jul 07, 2026

DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday - Benzinga

Jul 07, 2026

Jul 05, 2026

Aktis Oncology (AKTS) Gains 2.8% as Biotech Sentiment ImprovesVolume Breakout Ideas - dars.gov.et

Jul 05, 2026

Jul 04, 2026

Aktis is a strong buy at Raymond James on therapeutic platform - MSN

Jul 04, 2026

Jun 30, 2026

AKTS Q1 2026 Earnings: Results Miss Estimates as Pre-Revenue Biotech Continues Development - dars.gov.et

Jun 30, 2026

Jun 25, 2026

Aktis Oncology, Inc. Actuals & Estimates (NASDAQ:AKTS) - TradingView

Jun 25, 2026

Jun 25, 2026

AKTS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Aktis Oncology, Inc. News — NASDAQ:AKTS - TradingView

Jun 24, 2026

Jun 21, 2026

Aktis Oncology, Inc.(NasdaqGS: AKTS) added to S&P Global BMI Index - marketscreener.com

Jun 21, 2026